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Recurrent R162W mutation of keratin 9 has been reported
in multiple families with epidermolytic hyperkeratosis
(EHK)-type hereditary palmoplantar keratoderma (PPK).
Recently, we have observed a family whose members
showed autosomal-dominant PPK with unique histologic
features such as rounded, dissociated, and slightly eosino-
philic keratinocytes at the middle spinous and granular
layers of epidermis, but without the distinct EHK pheno-
Among various intermediate filament proteins, the ker-atins, expressed in epithelial cells, constitute the largestand most complex group. Keratins function in part ascytoskeletal components that are thought to be crucialin the maintenance of the structure of the epithelium
(Klymkowsky, 1995). The expression of keratin is regulated during
differentiation and proliferation in a tissue-specific manner. In normal
human epidermis, keratin 5 and 14 are expressed in basal cells. As basal
cells progress to terminal differentiation, keratin 5/14 expression is
downregulated, and other types of keratin, keratin 1 and 10, are
expressed in the suprabasal and spinous layers of the epidermis. In the
most upper spinous and granular layers, another keratin, keratin 2e, is
expressed (Galvin et al, 1988).
Recently, some congenital keratinization disorders and congenital
blistering diseases were found to be caused by mutations in keratin
genes. For example, epidermolysis bullosa simplex, in which blistering
and disassembly of the keratin network are observed in the basal cells,
was found to be caused by mutations in keratin 5 or 14 that are
expressed exclusively in the basal cell (Goldsmith, 1995). Working
with the hypothesis that morphologic abnormality of keratins, such as
clumped keratins as well as cell lysis, may be caused by the mutations
in keratins specifically expressed in the respective layers of the epidermis,
mutations of keratin 1 or 10 in epidermolytic hyperkeratosis (or bullous
congenital ichthyosiform erythroderma), and mutations of keratin 2e
in ichthyosis bullosa of Siemens have been studied and found to be
causative in these diseases (Rothnagel, 1996). Similarly, mutations of
keratin 9, which is specifically expressed in the palmoplantar epidermis
and outer root sheath epithelium, have been detected in epidermolytic
palmoplantar keratoderma.
Palmoplantar keratoderma is a group of heterogeneous genetic skin
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type. To investigate the genotype-phenotype correlation
in this family, we searched for a mutation of keratin 9
and found R162W substitution in the coiled 1A region.
This mutation was not detected in 50 control individuals.
These results may further our understanding of the
pathogenesis of EHK. Key words: keratin 9 mutation/palmo-
plantar keratoderma/phenotype. Journal of Investigative Derma-
tology Symposium Proceedings 4:150–152, 1999
diseases characterized by diffuse keratosis of the palms and soles. Among
these diseases, epidermolytic palmoplantar keratoderma (EPPK) is an
autosomal dominant disease characterized histologically by vacuolar
alteration of the cells in the middle spinous and granular layers of the
epidermis (epidermolytic hyperkeratosis; EHK). Recently, mutations
at the 1A region of keratin 9 have been reported in multiple patients
with this disease (Bonifas et al, 1994; Hennies et al, 1994; Reis et al,
1994; Torchard et al, 1994; Navsaria et al, 1995; Rothnagel et al, 1995;
Kobayashi et al, 1996; Endo et al, 1997), suggesting that a highly
conserved sequence at the beginning of the α-helical rod domain of
keratin 9 is essential for keratin-filament assembly in the epidermis of
the palm and sole.
More recently, we have observed a family whose members showed
autosomal-dominant PPK with scant and minimal vacuolar alteration of
the keratinocytes, but without the distinct EHK phenotype (incomplete
EHK). These findings prompted speculation that a novel mutation of
keratin 9 might underlie the unique histology of the patients. To
investigate the genotype-phenotype correlation of the patients, we
initially searched for the DNA segments corresponding to helix
initiation and termination peptide portions in the helix rod domain of
keratin 9. This led to the detection of an R162W substitution in the
coiled 1A region. This mutation appeared to be specific to the
family studied.
PATIENTS AND METHOD
A 6-month-old boy visited our out-patient department with a history
of palmoplantar keratoderma that had gradually increased from birth.
His father (36 y old) had similar clinical features. The father showed
diffuse keratosis restricted to the palms and soles with well-demarcated
erythematous borders. Interestingly, the keratosis was seen prominently
on the right palm, and less on the left palm (Fig 1). His mother was
not affected. A skin biopsy from the left palm of the father revealed
marked hyperkeratosis and acanthosis (Fig 2A), as well as a thickened
granular layer with focally pale-stained keratinocytes and enlarged
keratohyaline granules (Fig 2B, arrow). In the middle spinous and
granular layers, cells with minimal vacuolar alterations and enlarged
keratohyaline granules were only focally observed (Fig 2C, arrow). In
contrast, increased intercellular spaces and dissociation of keratinocytes,
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Figure 1. Clinical features of the affected father. The keratosis is diffuse
and restricted to the palms and soles with a well-demarcated erythematous
border. The keratosis is prominent on the right palm, and less on the left palm.
His son displays similar clinical features.
Figure 2. Skin biopsy from the left palm of the father. There are marked
hyperkeratosis and acanthosis (A), as well as a thickened granular layer with
focally pale-stained keratinocytes and enlarged keratohyaline granules (B, arrow).
In the middle spinous and granular layers, vacuolar alteration of the cells with
enlarged keratohyaline granules is seen, but they are scant and only focally
visible (C, arrow). In contrast, increased intercellular spaces and dissociation of
keratinocytes, as well as rounded, slightly eosinophilic keratinocytes, are seen
mainly in the middle spinous layer (C). Parts (B) and (C) are magnifications of (A).
Figure 3. Confirmation of the C to T transition at codon 162.
Oligonucleotide specific to the mutant allele hybridized only to the PCR
products from affected individuals (j), and not to that from the unaffected
individual in the family (s) and to those of the 50 control individuals (data
partially shown; C, control individuals).
as well as rounded, slightly eosinophilic keratinocytes were observed
mainly in the middle spinous layer (Fig 2C).
DNA samples were extracted from peripheral blood leukocytes of
both affected and unaffected individuals in the family, and from 50
control individuals without PPK, according to the standard procedure
(Bonifas et al, 1994). Because we speculated that a novel mutation of
keratin 9 might underlie the unique histology of the affected individuals,
we initially searched for mutation of the DNA segments corresponding
to helix initiation and termination peptide portions in the helix rod
domain of keratin 9. The DNA segments were amplified by polymerase
chain reaction, and cloned using a TA cloning kit (Promega, Invitiogen,
San Diego, CA). Several clones were sequenced using an automated
DNA sequencer (ABI PRISM 310 Genetic Analyzer) according to the
manufacturer’s procedures using vector arm primers. The 1A region
of keratin 9 was amplified by using specific primers 59-TTGGCTACA-
GCTACGGCGGAGGAT-39 (BK-11) and 59-TGAGATCATCAAT-
AGTGTTATAAT-39 (BK-21), which correspond to 269~697 bp of
the established genomic sequence (Reis et al, 1994). The helix
termination portion was also amplified using the primers 59-GAGGAG-
TTATGATGTAGCATCC-39 (BK-15) and 59-TCCTCTTCCATAA-
CTGCCTCCA-39 (BK-24B), which correspond to 2654~3417 bp of
the established genomic sequence. PCR cycling was done initially at
94°C for 5 min, followed by 35 cycles at 95°C for 45 s, 57°C for
2 min, 72°C for 2 min, and finally 72°C for 7 min. To confirm the
presence of the R162W (CGG to TGG) mutation in keratin 9 detected
in this family, PCR products amplified from all individuals in the
family, and from 50 control individuals, were hybridized after dot-
blotting with end-labeled allele-specific oligonucleotides 59-GGC-
CAGCCAAGAATTGAGT-39 (mutant) and 59-GGCCAGCCG-
AGAATTGAGT-39 (wild-type), according to Reis et al (1994).
Hybridization was done at 58°C for 3 h in 53SSPE, 53Denhart’s,
and 0.1% sodium dodecyl sulfate. Membranes were washed with
13SSC, 0.1% SDS at 65°C for 3 min, and visualized by autoradiography.
RESULTS
R162W (CGG to TGG at codon 162) mutation was detected in the
1A region of keratin 9 in the affected individuals. This mutation was
detected neither in the unaffected individual in the family nor in the
five control individuals sequenced (data not shown). C to T transition
at codon 162 was confirmed by the hybridization of Southern blot of
PCR products amplified from all individuals in the family and from the
50 control individuals with end-labeled allele-specific oligonucleotides
(ASO). ASO specific for the mutant allele hybridized only to the PCR
products from the affected individuals in the family, not to those from
the unaffected family member or from the 50 control subjects (data
partially shown in Fig 3).
DISCUSSION
In past studies, mutations of keratin 9 in EPPK were thought to be
restricted to codons 156–176 in the 1A region of the α-helical rod
domain (Bonifas et al, 1994; Hennies et al, 1994; Reis et al, 1994;
Torchard et al, 1994; Navsaria et al, 1995; Rothnagel et al, 1995;
Kobayashi et al, 1996; Endo et al, 1997; data also summarized in the
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Human Gene Mutation Database, HTTP://www.uwcm.ac.uk/uwcm/
mg/hgmd0.html). In addition, Kimonis et al (1994) and Shamsher et al
(1995) have reported mutations in the V1 end domain of keratin 1 and
1A region of keratin 16 in nonepidermolytic PPK. These observations
suggested that mutations of keratin 9 are specific to EPPK, and that
mutations in other keratin genes such as keratins 1 or 16 might underlie
the non-EPPK phenotype.
Of the keratin 9 mutations reported previously, the incidence of
R162W substitution is estimated at 47% (eight of a total of 17 total
cases), suggesting that this mutation is the most frequent in EPPK
patients. In fact, in this study, R162W mutation was detected in a family
of autosomal-dominant PPK with histologically altered keratinocytes in
the middle spinous and granular layers, but without the distinct EHK
phenotype (incomplete EHK). These findings suggest that mutations
at the beginning of the α-helical rod domain of keratin 9 should
initially be screened for even when we observe an EPPK patient
without distinct EHK formation.
Moreover, these findings suggested several possibilities: first, that the
activity of ‘‘epidermolysis’’ in EPPK might gradually decrease as the
patient ages, as is likely in the case of epidermolysis bullosa simplex;
second, that other cellular components such as other types of keratins
and adhesion molecules unique to the patient might help to prevent
serious disruption of keratin intermediate filaments; and third, that
other external factors such as the friction and mechanical abrasion to
the skin of the father might have been insufficient to induce the
distinct EHK phenotype. The idea that mutations in the keratin 9
gene are essential, but not sufficient, for the formation of EHK, may
account for the fact that re-examination of the family originally
reported by Thost (in his report, the family did not show EHK
histologically) demonstrated the characteristic features of EHK (Koester
and Becker, 1992). Further pathophysiologic studies of the unique
histology observed in this family might give us more information for
better understanding the mechanism of EHK formation.
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